Do you have bladder cancer that has spread to nearby tissue or other parts of the body? You may be able to participate in a research study to find out if the investigational drug disitamab vedotin alone or with pembrolizumab works to treat bladder cancer.
Do you have Stage III or Stage IV Non-Small Cell Lung Cancer? Do you have a KRAS G12C mutation or are you interested in testing for this? If so, you may be able to participate in a study to see if adding a new medicine is more effective at controlling your cancer than the usual treatments.
Do you want to experience a nurturing, empowering and wellness-centered prenatal care that helps you reduce the chance of getting diabetes in pregnancy? Then the Targeted Lifestyle Change (TLC) Study might be for you! TLC is specially designed to help you learn how to eat, move, and live for two during pregnancy to explore whether we can reduce the risks of diabetes in pregnancy. Compensation provided.
Have you ever noticed yourself repeatedly thinking or doing specific things? Have you experienced symptoms of OCD now or in the past (even if you did not seek treatment)? Do you identify as Black? If you have (or think you might have) OCD, you may be able to participate in a study to learn more about OCD and new methods for prevention and treatment. Participants will receive $50.
Do you have bladder cancer and have had your bladder removed? If so, you may be able to take part in a research study to determine if patients need additional treatment called immunotherapy to prevent cancer from coming back.
Have you ever been concerned about your eating? We're inviting adults in the U.S. who have ever had anorexia nervosa, atypical anorexia nervosa, bulimia nervosa, binge-eating disorder, or avoidant/restrictive food intake disorder (ARFID) at any point in their life to take our survey. No official medical diagnosis is required. Common signs of different eating disorders may include: restricting the amount or type of food you eat or eating excessive amounts of food in one sitting. Some other possible signs are making yourself throw up, using diet pills or laxatives, excessively exercising, or fasting to alter your weight. Only with your help can we the causes and potential cures for these disorders. Eligible participants who complete Core Questionnaires and return their saliva sample will receive a $30 gift card.
Have you been diagnosed with pancreatic adenocarcinoma? If so, you may be a good fit to help us learn if combination treatment with specific drugs may stimulate the body's immune system against cancer cells.
The UNC MOTION Science Institute is seeking volunteers with a history of anterior cruciate ligament (ACL) reconstruction surgery and healthy controls for a research study on the effects of stroboscopic vision on walking gait biomechanics, and how the somatosensory function may influence these changes. Individuals who have injured their ACLs are at a high risk of developing post-traumatic osteoarthritis, in part due to altered gait biomechanics. Stroboscopic vision has been shown to alter biomechanics in other tasks and populations, but its effects on walking biomechanics following ACL reconstruction is unknown.
Have you been diagnosed with Multiple Myeloma? Have you received idecabtagene vicleucel (ide-cel (Abecma)) CAR-T treatment? If so, you may be able to take part in a research study looking at for how long a new drug called iberdomide will keep Multiple Myeloma under control (in remission).
This study aims to understand how a person's race and where they live affect the quality of breast cancer care they receive. We invite Black and/or African American breast cancer patients and survivors from specific areas of North Carolina to participate in a virtual focus group. The purpose of this focus group is to get your feedback about maps and other tools our team has created to show how breast cancer care quality varies around the state and by race. We also want to hear your experiences seeking care in your area, and your ideas about possible reasons behind the patterns in your area.